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1. Introduction 
The choroid, the most important vascular tissue of the eye, is made up of vascular layers of 
descending thicknesses, from the large-sized choroidal vessels close to the sclera, to the 
choriocapillaris underlying the retina. Some 85% of the blood flow of the eye circulates 
through the choroidal vessels. The most important functions of the choroid include the regu-
lation of eye temperature and the nutrient supply to the outer retinal layers, in which is-
chaemia would seriously compromise visual function. The integrity of the cells of the vascu-
lar endothelium and of the smooth-muscle cells therefore proves essential to maintain the 
choroidal flow [1]. 
The rise of the plasma-cholesterol levels is known to be accompanied by an overexpression 
of monocytic chemotactic protein-1 (MCP-1) by the macrophages and vascular smooth-
muscle cells, which play a pivotal role in the development of fatty streaks [2]. In this way, an 
endothelium altered by hypercholesterolaemia leads to a pre-thrombosis state that begins 
with the aggregation of platelets. This is contributed to by aggregates that accumulate in the 
intima of the arteriolar wall as a result of the interaction of low-density lipoprotein (LDL) 
with the extracellular matrix [3,4]. Endothelial dysfunction precedes atherosclerosis, which 
is characterized by the expression of two adhesion molecules, the vascular adhesion mole-
cule-1 (VCAM-1) and the inter-cellular adhesion molecule-1 (ICAM-1). Both participate in 
the adhesion and extravasation of the monocytes into the subendothelial space, where they 
are transformed into macrophages. These subendothelial macrophages participate in trans-
forming the LDL into highly oxidized LDL (oxLDL), which after being taken up by the mac-
rophages contributes to the formation of foam cells [5] such as those seen in the large cho-
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roidal vessels and in the suprachoroid of hypercholesterolaemic rabbits [6]. The saturation 
of the foam cells leads to their death and the release of toxic products such as esterified and 
oxidized cholesterol, a scenario that inflicts greater endothelial damage and encourages the 
progression of the atherosclerotic lesion. 
The change in cell activation is measured by factors such as the nuclear factor kappa-beta 
(NF-kB) detected in macrophages, vascular endothelial cells, and smooth-muscle cells of 
atherosclerotic lesions [7]. The proliferation of smooth-muscle cells towards the intima, 
associated with an increase in apoptosis and a decrease in inflammatory cells, could indicate 
an attempt to limit the lesion. These processes described in hyperlipaemic aortas are also 
found in the walls of the large choroidal vessels, where, in addition to hypertrophy of the 
smooth-muscle cells, a great quantity of lipid inclusions appear and, in the case of choroidal 
arterioles, an increase in collagen fibre of the intima and the adventitia [8]. 
Several mechanisms contribute to impaired vascular tone in atherosclerosis, such as the 
activation of the smooth-muscle cells, by e.g. the synthesis of the extracellular matrix in-
duced by the macrophage-derived TGF-beta, the intimal thickening and the changes in the 
vascular endothelium, including the release of mediators that promote vascular constriction 
[9]. Clinical studies have suggested that hyperlipidaemia alone can prompt structural 
changes in the choroidal vascular and retinal system which over time could provoke retinal 
dysfunction [10]. Chronic ischaemia is also present in causes of blindness as prevalent as 
aged-related macular degeneration, glaucoma or diabetic retinopathy [11-13]. 
In summary, this chapter illustrates the structural and ultrastructural changes that occur 
experimentally in the choroids of animals subjected to a hyperlipaemic diet; the changes that 
appear in this tissue when the plasma-cholesterol levels are normalized after the hyper-
lipaemic diet is replaced by a standard one, and the effects in vascular tissue, fundamentally 
the mitochondria and the caveolar system of the endothelial and smooth-muscle cells, 
caused by the treatment with statins at such low rates that they do not alter the high choles-
terol levels (pleitropic effects) but are effective for controlling chronic ischaemia. 
2. Anatomo-physiology of the choroid 
2.1. Anatomy of the choroid 
The choroid constitutes the most posterior region of the tunica intermedia of the eyeball or 
uvea. This is formed by a pigmented vascular tissue underlying the sclera and overlying the 
retina. Histologically, the choroid has three layers, which from the sclera towards the retina 
are: the suprachoroid, the vascular layer, and Bruch’s membrane (Figure 1A). 
2.1.1. Suprachoroid 
The suprachoroid is the outermost layer of the choroid, a transition zone between the 
innermost part of the sclera and the large-sized-vessel layer (Fig. 1A). It is composed of 
tightly packed collagen fibres, melanocytes [14], fibroblasts [15], elastic fibres [16], 
 
Choroidal Vessel Wall: Hypercholesterolaemia-Induced Dysfunction and Potential Role of Statins 
 
257 
smooth-muscle cells [16-18], nerve plexus, and intrinsic choroidal neurons (ICNs) [19-21]. 
In primates, birds, and rabbits, this layer contains large, endothelium-lined spaces, which 
empty into veins. 
 
Figure 1. Choroidal vascular layers. A: Histological section (hematoxylin/eosin). B: Tridimensional 
scheme (Modified with permission from Ramírez et al. [19]). 1: Sclera; 2: Suprachoroid; 3: Large-sized- 
vessel layer (Haller´s Layer); 4: Medium-sized-vessel layer (Sattler´Layer); 5: Choriocapillaris; 6: Bruch´s 
membrane; 7: retinal pigment epithelium. 
2.1.2. Choroidal-vessel layers 
Most of the choroid consists of blood vessels that decrease in diameter from outer to inner as 
the vessels branch. It is made up of arteries, veins, arterioles, and a vascular stroma (Figure 
1A,B). The latter contains collagen and elastic fibres, fibroblasts, non-vascular smooth cells, 
numerous melanocytes, mast cells, macrophages, and lymphocytes. The arterial vessels are 
branches of the posterior ciliary arteries (PCAs) (Figure 2) and some recurring branches of 
the major arterial circle of the iris [22]. The vessels become smaller in a branching hierarchy 
towards the capillary bed, enabling the identification of the three vessel layers of decreasing 
calibre [23]: an outer layer of large-sized vessels (Haller’s layer), an intermediate layer of 
medium-sized vessels (Sattler’s layer), and inner layer of interconnected capillaries (the 
choriocapillaris) (Figure 1A,B).  
Large- and medium-sized-vessel layers 
Before penetrating the sclera, the PCAs are subdivided into various branches that surround 
the optic disc: two long posterior ciliary arteries (LPCA) [22,24] and 15-20 short posterior 
ciliary arteries (SPCA) [25] (Figure 2). Depending on their scleral penetration, the SPCA can 
be further subdivided into paraoptic SPCA (closer to the optic disc) and distal SPCA [26,27]. 
Overall, 2 paraoptic SPCA pass through the sclera and surround the optic disc, thus forming 
the Zinn-Haller arterial circle, which provides blood flow to the circumpapillary choroid 
and the prelaminary and laminary regions of the optic nerve head [27,28] (Figures 2,3). The 
rest of the SPCA, both paraoptic as well as distal, once in the vascular choroid, divide secto-
rially, forming triangular areas towards the 4 regions of the eyeball. The macular region is 
irrigated by a dense network of distal branches of the SPCA [29,30].  
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The LPCA penetrate the eyeball at some 4 mm from the optic disc in the horizontal meridi-
ans following a rectilinear path in the most superficial part of the layer of large vessels 
[24,27] (Figure 2). These arteries help constitute the major arterial circle of the iris [25,31,32] 
and sends out recurrent branches toward the peripheral choroid [32,33]. 
As opposed to what happens throughout most of the human vascular system, the arterial 
and venous systems of the choroid are not parallel, as most of the veins are located primari-
ly in the most external choroid [33]. The proportion of arteries to veins varies throughout the 
choroid, as does capillary density. In the latter case, density progressively diminishes from 
the centre to the periphery, coinciding with the fall in the number of photoreceptors of the 
retina. Thus, the submacular choroid is the one with the greatest capillary density (greatest 
quantity of blood per unit of area), this being necessary to nourish the great number of pho-
toreceptors of the macula [23]. In this zone, the arteriole/venule ratio is 3:1, so that the foveal 
cones can have double their blood supply, even at the cost of greater risk of oedema by vein 
blockage. At the posterior pole, the arteriole:veinule ratio is 1:2 to 1:4 [34,35]. As a result, 
these zones of the choriocapillaris could be more susceptible to local blockages of arteries, 
with the consequent risk of ischaemic damage. 
The voriticose veins drain the entire choroid, the ciliary body, and the iris. These veins are 
located at the equator (1 per each quadrant) and form a bottle shape receptacle before pene-
trating the sclera, which in turn is constituted by the meeting of 2 to 4 ampuliform dilations 
[27,36]. The choroidal veins and venules are larger than the arteries and maintain a rectiline-
ar path, joining at many acute angles before ending in the vorticose veins [15,23,33]. 
 
Figure 2. Scheme that represents the entry of the ciliary arteries in the eyeball. LPCA: Long posterior 
ciliary arteries; SPCA: Short posterior ciliary arteries; PCA: Posterior ciliary arteries. (Modified from 
Ramírez et al [72]). 
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Figure 3. Diafanization and repletion with colored polymers of two short posterior ciliary arteries 
(SPCA) forming the Zinn-Haller arterial circle. (Modified from Ramírez et al [72]). 
The choriocapillaris 
The choriocapillaris is made up of capillaries situated between the medium-sized vessel 
layer (Sattler’s layer) and Bruch’s membrane (Figures 1,4). The position of these capillaries, 
flattened and elliptical in transverse section, create a large surface for metabolic exchange 
with the retina. With the same purpose, the vessels of the choriocapillaris are composed of 
tubes of endothelial cells (EC) and pericytes that do not completely surround it, appearing 
only towards the scleral side. Meanwhile, the ratio of pericytes:endothelial cells in the hu-
man retina is 1:1, and in the choriocapillaris it is 1:6 [23]. Given the contractile character of 
these cells, which enables the blood supply to be regulated in other tissues, their lower 
number in the choriocapillaris could suggest that the regulation of the choroidal blood flow 
by contraction is practically nil [23]. 
The EC presents fenestrations in the side oriented towards Bruch’s membrane and retinal 
pigment epithelium (RPE) [37-39] (Figure 5). These fenestrations are of great physiological 
importance, as they permit the passage of nutrients towards the retina. The choroid capillar-
ies are permeable to small molecules such as glucose (20-fold more than in cardiac muscle 
and 80-fold more than in skeletal muscle) [40] and amino acids [41], as well as large mole-
cules such as γ-immunoglobulin and vitamin A [40,42,43]. Endothelial cells send out pro-
longations towards Bruch’s membrane [44] that could physically stabilize the angioarchitec-
ture of the inner choroid [45]. In addition, these prolongations could be involved in process-
es of phagocytosis for the elimination of waste products of Bruch’s membrane [46], which 
would give them an important function in the metabolic exchange between the choroid and 
the RPE [47].  
Among the capillaries of this layer are collagen fibres that form intercapillary septa [48]. 
These septa are reinforced and intermixed with fibres that come from the collagen area of 
Bruch’s membrane [23]. In this way, the capillaries are immersed in a network of relatively 
rigid collagen that prevents collapse [15]. 
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2.1.3. Bruch’s membrane 
The innermost layer of the choroid is Bruch’s membrane. This is an acellular structure, easily 
distinguishable from the retina and the choroid, and contains elements of both tissues. Ac-
cording to studies made with the electron microscope [15] [49][49][49] it can be divided into 
five layers, which, from the choroid side towards the retina are: The basal membrane of the 
choriocapillaris, the outer collagen layer, the elastic-fibre layer, the inner collagen layer, and 
the basal membrane of the RPE (Figure 5). 
The basal membranes, which on one side separate Bruch’s membrane from the choriocapil-
laris, and on the other from the RPE, are not joined by the hemidesmosomes to their adja-
cent layers [50]. The basal membrane of the choriocapillaris is discontinuous [15], being 
present on the side of the endothelium of the capillaries but absent in the intercapillary 
spaces [50]. 
The two collagen layers, with a thickness of 1 μm in young individuals, surround the layer 
of elastic fibres [15]. Some collagen fibres are arranged parallel to the plane of the tissue, 
particularly at the level of the inner collagen. Others pass from one side to the other of the 
elastic-fibre layer, interconnecting both collagen layers [15,33]. Through the external colla-
gen, fibres penetrate the interruptions of the basal membrane to join the collagen fibres of 
the intercapillary septa (as described above). This arrangement can help to join Bruch’s 
membrane to the choriocapillaris. 
The elastic fibre layer lies between the inner collagen layer on the inside and the outer colla-
gen layer on the outside. It is made-up of inter-woven bands of elastic fibres 2-4 μm thick. 
Between these appear irregular spaces through which the collagen fibres pass [15]. 
 
Figure 4. Histologic section of the choriocapillaris (CC), Bruch's membrane (BM) and retinal pigment 
epithelium (RPE). Hematoxylin/eosin. (Modified from Ramírez et al [72]). 
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Figure 5. Electron micrograph of Bruch´s membrane (BM) and choriocapillaris (CC). Bruch´s membrane 
is composed of several layers: the basal membrane of the retinal pigment epithelium (RPE), the inner 
collagenous layer (IC), the elastic layer (E), the outer collagenous layer (OC) and the basal membrane of 
the choriocapillary endothelium. Endothelial cells (EC) of the choriocapillaris present fenestrations 
(arrow-head). 
2.1.4. Choroidal innervation. 
The abundant choroidal innervation is made up of fibre bundles from the sympathetic and 
parasympathetic (autonomic nervous system) and sensitive (central nervous system). The 
sympathetic fibres are from the superior cervical ganglion, the parasympathetic from the 
ciliary and pterygopalatine ganglion, and the sensitive fibres from the trigeminal ganglion. 
These nerve fibres reach the choroid in three ways: i) going around the SPCA, these fibres 
stem from the plexuses of the internal carotid and continue with the ophthalmic artery until 
reaching the SPCA in the choroid; ii) through the short posterior ciliary nerves that stem 
from the ciliary ganglion; or iii) through the long posterior ciliary nerves that come from the 
nasociliary nerve [19,20] (Figure 6). In addition to the nerve fibres, the choroid has intrinsic 
choroidal neurons (ICNs). Both nervous structures are more abundant in the suprachoroid 
than in the rest of the vascular layers, with no innervation in the choriocapillaris [20]. 
Nerve Fibres 
The long ciliary nerves (nasal and temporal) enter the choroid together with the LPCA, in 
the horizontal meridian of the eye, near the optic disc. They head towards the anterior part 
of the eyeball, with few branches in the part towards the suprachoroid or the choroidal 
vessel layers [20] (Figure 6). The short ciliary nerves enter the choroid together with the 
SPCA around the optic nerve and proceed towards the ciliary body. In this trajectory, there 
are many branches for the suprachoroid and the choroidal vessel layers [20] (Figure 6).  
The short and long ciliary nerves send out branches to the large-sized-vessel layer of the 
choroid that are arranged in a paravascular form (Figure 7). Immunohistochemical tech-
niques have demonstrated that these paravascular axons carry information which is sympa-
thetic [NPY(+) and TH(+)] [21]; parasympathetic [(VIP(+)], and sensitive [SP(+) and 
CGRP(+)] [51]. In addition, in the vascular walls, sympathetic perivascular ends [NPY(+) and 
TH(+)] as well as sensitive ones [SP(+) and CGRP(+)] have been described. These perivascu-
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lar fibres can present small end dilations on reaching the vascular wall. Some axons pene-
trate to a deeper level of the medium-sized-vessel layer to form a polygonal plexus. This 
axons are sympathetic [NPY(+) and TH(+)] and sensitive [SP(+) and CGRP(+)]. Innervation 
has not been demonstrated in the choriocapillaris [21,51,52]. 
 
Figure 6. Tridimensional scheme showing the topographic distribution of the short ciliary nerves (SCN) 
and long ciliary nerves (LCN) in human choroid. The short ciliary nerves form a plexus of nerve fibers 
in the suprachoroid. In the vascular layers, the scheme shows branches from this plexus adapting to the 
vessel contours - paravascular fibers (PF) and intervascular fibers (IF). ON: optic nerve; PSCA: short 
posterior ciliary arteries; PLCA: Long posterior ciliary arteries; VV: vorticose vein; asterisk: posterior 
pole. (From Triviño et al. [20] 
 
Figure 7. Human choroidal wholemount. Nerve fibers adapted to the choroidal vascular morphology 
(paravascular fibers) lying parallel to the large arteries (arrow-head). Anti NF-200 PAP. Bar: 250 μm. 
(From Triviño et al. [20]) 
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Intrinsic choroidal neurons (ICNs) 
Besides nerve fibres, the human choroid possesses abundant ICNs (from 1300 to 1500), 
which are located mainly in the suprachoroid (Figure 8). The greatest concentration of ICNs 
is found in the central and temporal region adjacent to the macula. This location could be 
related to the existence of the macula. In humans, ICNs could be responsible for regulating 
the rapid vasoregulatory reflexes, which are so important in the fovea [20]. 
 
Figure 8. Intrinsic choroidal neurons of the suprachoroid forming a microganglion. Double immuno-
fluorescence for NF 200 (green) and TH (red). Bar: 20 μm. (From Triviño et al. [21]) 
The ICNs can present immunoreactivity to VIP (parasympathetic) and to nitric oxide syn-
thase (NOS), indicating the use of nitric oxide (NO) as a neurotransmitter. Both the NO and 
the VIP would be involved in the vasodilation through the regulation of the vascular 
smooth-muscle fibre. Recently, ICNS have been reported to be immunoreactive to NPY and 
TH (sympathetic) (Figure 8) and to SP and CGRP (sensitive) [52]. All these are located pref-
erentially in the central region of the temporal area (submacular choroid). Sympathetic ICNs 
could exert a protective mechanism to prevent over-perfusion and breakdown of barriers 
[21]. Sensitive ICNs could be involved in regulating the ocular blood supply, inflammatory 
processes, and vascular architecture [52]. 
2.1.5. Ultrastructural anatomy 
Choroidal arteries and veins 
The choroidal arteries have the structure of small arteries. They are constituted by a tunica 
intima, which consists of a monolayer of EC, a basal membrane often containing a cluster of 
fine osmophilic particles and of interspersed elastic fibres [15]. The intima is surrounded by 
a thick tunica media made up by one or more layers of smooth-muscle cells (Figure 12A). In 
larger arteries, there are two to three layers of smooth-muscle cells, the innermost arranged 
circumferentially and the outermost obliquely or longitudinally. These cells are separated 
from each other by basal membranes [53]. Over the tunica media lies an adventitia of colla-
gen in a circular arrangement but without an outer elastic membrane. In the adventitia, 
there are often melanocytes and fibroblasts [54]. The choroidal arterioles are constituted by: 
an intima, formed only by an endothelium and a basal membrane without inner elastic; a 
tunica media made up of a discontinuous muscle layer; and an adventitia formed by a fine 
layer of circular collagen [15]. 
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Choroidal veins have a structure similar to the rest of the veins of the organism, are com-
posed of an endothelia, a basal membrane, one or two layers of muscle cells, and an adventi-
tious layer of collagen [23]. Clusters of unmyelinated axons and synaptic terminals reach the 
outer muscle layers of the veins and arteries. Terminal boutons make contact with the 
smooth-muscle cells [53]. 
The EC, both of the arteries as well as of the choroid veins, present evaginations that pro-
trude towards the inside of the vessel and towards the basal membrane. These later pass 
through the membrane and make contact with the closest muscle cells. In the cytoplasm of 
the EC the normal organelles can be found: mitochondria, Golgi apparatus, rough endo-
plasmic reticulum, caveolar system, free polyribosomes, cytoplasmic vesicles and Weibel-
Palade bodies, which are membrane-bound granules containing an electrodense material 
[54,55]. The processes of the EC overlap and are joined together by different types of cell 
bonds: zonula adherens, tight junctions, and long gap junctions [38] (Figure 13A). 
The vascular smooth-muscle cells (VSMC) contain an elongated, highly heterochromatic 
nucleus, a cytoplasm with elongated mitochondria having smooth and rough-surfaces, 
endoplasmic reticulum, and numerous contractile filaments oriented parallel to one other [54]. 
Among the bundles of filaments appear dense osmiophilic structures that resemble Z bands, 
which probably represent areas of attachment of the filaments. Other filaments are oriented 
towards thickenings of the cell membrane; the filaments join these thickenings in the same 
way as hemidesmosomes [15]. Alternating with the dense structures, rows of caveoles appear 
along the surface of the cell membrane [55]. The muscle cells are joined together by macular 
adherent junctions, punctiform junctions, and gap junctions [54] (Figure 13A). 
Choriocapillaris 
The capillaries of the choriocapillaris differ from those of the retina by the great diameter of 
its lumen, in such a way that red blood cells can pass through at least 2 or 3 at a time 
[23].The EC of these capillaries have their nuclei located on the side of the vessels opposite 
Bruch’s membrane and protrude slightly into the lumen. Its cytoplasm, contains scattered 
mitochondria, small portions of Golgi apparatus, short cisterns of rough endoplasmic reticu-
lum, free polyribosomes, cytoplasmic vesicles, caveolar system, and occasional Weibel-
Palade bodies [54]. 
The EC are joined together by thin discontinuous bonds (zonula occludens), desmosomes, 
and communicating junctions (gaps) [37,38,56]. In addition, they have the peculiarity of 
presenting fenestrations on the side oriented towards Bruch’s membrane and the RPE [37-
39]. These fenestrations have a mean pore size of 60-80 nm [15,23] and are crossed by a dia-
phragm with a central density [37] (Figure 5). Endothelial-cell processes protrude into 
Bruch’s membrane, typically at sites of focally thickened, nonfenestrated regions of the EC 
[46]. The endothelium is enveloped by a thin basal lamina which also surrounds the peri-
cytes [14,57,58]. Pericytes appear only on the scleral face of the capillaries, incompletely 
wrapping them [23]. In their cytoplasm, pericytes bear small bundles of microfilaments, 
preferentially located along the plasma membrane [54,59]. 
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The stroma (extravascular tissue) contains collagen and elastic fibres, fibroblasts, non-
vascular smooth-muscle cells and numerous very large melanocytes closely apposed to the 
blood vessels. As in other types of connective tissue, numerous mast cells, macrophages and 
lymphocytes appear ([60] (Figures 11A,12A). 
2.2. Choroidal physiology 
The choroid is one of the most vascularized tissues of the human body and therefore it has 
traditionally been thought that its main function was to nourish the external layers of the 
retina. However, today it is known that it has many other functions, including: light absorp-
tion, elimination of the aqueous humour from the unveoscleral pathway, adjustment of the 
position of the retina by changes in the choroid thickness, help in the control intraocular 
pressure, and thermoregulation. The latter two functions of the choroidal blood flow have a 
fundamental role. 
2.2.1. The role of the choroidal blood flow 
The choroidal blood flow represents some 85% the total blood in the eye [34]. This high flow 
rate considerably surpasses that of other richly vascularized tissues, being 10-fold higher 
than in the grey matter of the brain, and 4-fold that of the kidney. This high choroidal blood-
flow rate (800-2000 ml/min/100 gr of tissue) is probably due to the great calibre of the vascu-
lar lumen of the choriocapillaris, and therefore to its low flow resistance [24,61]. Further-
more, the blood flow is not uniform, as it presents regional differences throughout the cho-
roid, so that on the periphery the flow is 6- to 7-fold lower than in the central regions (foveal 
and peripapillary) [62]. 
The exact function of the high choroidal blood flow is still not known with exactitude. Phys-
iologically, one of the main functions of the choroid is to nourish (supply O2 and glucose) to 
the most external layers of the retina (fundamentally to the photoreceptors and to the RPE). 
In many species, the retina depends entirely on choroidal circulation for its metabolic needs. 
The human choroid provides the metabolic requirements to the entire thickness of the retina 
only in the macular region. The high choroidal blood flow results in a steep gradient for the 
diffusion of O2 towards the external layers of the retina and a low concentration of waste 
products, facilitating their elimination from the retina [1]. If we take into account that vein 
blood is approximately 95% of that found in the arterial blood, we see that the O2-extraction 
rate from choroidal arterial blood is only 3-5% [63]. However, the high blood flow through 
its vessels permit the choroid to provide a high percentage of oxygen consumed by the reti-
na.  
Nevertheless, the choroid appears to be perfused at a proportion that exceeds its nutritive 
needs, suggesting therefore an additional role for the high rate of choroidal flow. Thus, it is 
thought that the choroidal blood flow could help maintain the regulation of the intraocular 
pressure (IOP) [43] and, on the other hand, offer thermoregulation by the following mecha-
nisms: dissipating the heat generated during the visual transduction process [64], prevent-
ing overheating of the outer retina during exposure to bright light [65], and, finally, heating 
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the intraocular structures that could be cooled by exposure to extreme outside conditions 
[66]. 
2.2.2. Regulatory mechanisms of choroidal blood-flow 
The control of circulation in most tissue is quite complex, as there are many factors that 
influence vascular resistance, such as: local myogenic responses, substances derived from 
the endothelium, local metabolic factors, and the autonomous nervous system. The existence 
or not of choroidal self-regulating mechanisms has long been the object of debate. The pres-
sure that promotes blood flow through the tissues is called perfusion pressure. Ocular per-
fusion pressure is the difference between the pressure of the arteries that reach the eye (aP) 
and that of the veins that leave the eye (vP) [1]. The perfusion pressure and vascular re-
sistance (R) determine blood flow (F) according to the following formula: F=(aP-vP)/R. As in 
the eye, the vP is practically equal to the IOP both under normal conditions as well as in 
cases of increased IOP, so that the formula becomes: F=(aP-IOP)/R. According to this formu-
la, a decrease in the perfusion pressure (by relieved arterial pressure or greater IOP) could 
result in a proportional restriction of blood flow without a compensatory reduction in vas-
cular resistance [33]. 
In most tissues, blood flow tends to remain constant despite moderate variations in perfu-
sion pressure, thanks to the mechanism known as self-regulation [24]. However, in the 
choroid, as opposed to the retinal vessels and the prelaminary region of the optic disc, 
increases (even moderate ones) in the IOP, cause concomitant reductions of the choroidal 
blood flow [63]. This circumstance is not controlled by any self-regulated mechanism 
[67,68]. Nevertheless, some authors have considered there to be a certain self-regulatory 
capacity of choroidal circulation under very specific conditions. Thus, it has been demon-
strated that the choroidal circulation is sensitive to tensions of CO2 as well as to acidic 
metabolic products which cause vasodilation. Studies on cats have shown a marked vaso-
dilation in the choroid when the CO2 concentration is raised [69]. It has been observed 
that the flow augments with the respiration of air containing 10% CO2 and diminishes 
with respiration of air saturated with 100% O2 [70]. Other studies reveal evidence of cho-
roidal self-regulation when the average arterial pressure gradually weakens. This mecha-
nism is IOP dependent, so that its effect is far more pronounced at low IOP levels (< 5 
mmHg) and does not occur within normal or higher IOP ranges. Therefore, the choroid 
would be capable of regulating its circulation at extremely low perfusion pressures in-
duced by a fall in average arterial pressure. 
Neural control of choroidal blood-flow 
In recent years, the importance of the neural control in choroidal blood-flow regulation has 
been stressed. Several mechanisms are involved in the neuroregulation of the uveal flow. In 
a direct way, this flow is regulated by perivascular innervation, which permits a balance 
between the vasoconstriction and vasodilation necessary for the maintenance of blood flow. 
Indirect regulation comes from the paravascular fibres, both by means of classical neuro-
transmitters as well as neuropeptides released by sympathetic, parasympathetic, and stro-
ma-sensitive nerve endings, and diffusing factors such as NO [20]. 
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Sympathetic stimulation causes sharp choroidal vasoconstriction and a fall in intraocular 
pressure due to a decline in the ocular blood volume (reductions in choroidal flow of up to 
60%) [62]. This response comes fundamentally from the stimulation of α-adrenergic recep-
tors located in the VSMC [1]. The sympathetic innervation places the choroid under vaso-
constriction tone, suggesting that this could protect the retina and the optic nerve head from 
the hyperfusion and break of the ocular barriers that could appear under certain circum-
stances as for example arterial hypertension. The systemic hypotension would, by barrore-
flex, increase sympathetic activity and depress parasympathetic activity, which would in 
turn bolster vascular resistance in the choroid, with the consequent restriction in choroidal 
blood flow. This situation has not been confirmed in experimental studies [71], indicating 
that there could be a local mechanism in the choroid capable of ignoring neurogenic vaso-
constriction, or the choroidal nerves do not become activated during the discharge of the 
barroreceptors. Other authors [62,63] have demonstrated that, although during the direct 
stimulation of the sympathetic activity, it has little effect on the diminished choroidal flow 
during the hypotension induced by a haemorrhage. The existence of sympathetic neurons in 
the choroid (ICNs) immunopositive for NPY and TH [21], could partly explain the self-
regulatory capacity of the choroid. 
The role of the parasympathetic innervation it is not as clearly defined as the sympathetic 
one. However, it has been observed that the choroid responds to cholinergic parasympathet-
ic stimulation (which arrives through the short ciliary nerves) by vasodilation. This vasodi-
lation would explain the increase light-induced choroidal blood flow [72].  
Recently, it has been postulated that the sensitive peripheral nerves play an important role 
in choroidal blood-flow regulation. Thus, SP could have a viscero-motor function, regulat-
ing the choroidal flow during ocular irritation. In addition, a role in vasodilation has been 
attributed to the CGRP as a cholinergic co-mediator with the SP [52]. 
Neural control of choroidal blood flow in ocular diseases 
The importance exerted by nerve control on the regulation of choroidal blood flow appears 
to imply that damage in the choroidal innervation could be involved in the vascular altera-
tions that occur in some ocular diseases. Experimental studies have demonstrated that sym-
pathetic innervation is critical in the regulation of choroidal vascularization [73], and that 
the chronic loss of sympathetic activity can contribute to the anomalous vascular prolifera-
tion noted in diseases such as age-related macular degeneration (ARMD) [74] and diabetic 
retinopathy [75,76]. Furthermore, the loss of this innervation can cause oedema in the retina 
[71], a circumstance that could be important in illnesses such as diabetes or hypertension, in 
which automatic control is altered [56]. 
The axonal damage in the sympathetic nervous system is a notable fact of diabetic 
neuropathy. In addition, a dysfunction of the sympathetic nerves of the eye in diabetic 
patients has been suggested, postulating that the episodes of hyperglucaemia could 
determine an increase in the choroidal flow and in the pressure of the vessels in the 
submacular choroid, as well as changes in the RPE. In this way, the extravasation of fluid 
from the submacular choroid would be exacerbated. The excess of intraretinal liquid caused 
Current Basic and Pathological Approaches to  
the Function of Muscle Cells and Tissues – From Molecules to Humans 
 
268 
by diabetic macular oedema would not come from the retinal vessels alone but also from the 
choroid, reaching the retina through lesions of the RPE near the choriocapillaris affected 
[77]. 
In ARMD, haemodynamic anomalies have been reported as potential causal agents as part 
of the pathological process. By laser Doppler flowmetry, it has been observed that the 
choroidal blood flow diminishes with age [78], and it is lower in the non-exudative stages of 
macular degeneration than in control. This effect is due to a descent in the volume of blood 
flow [79]. 
Recently, it has been postulated that the sensitive nerves could be involved in regulating 
choroidal flow through different inflammatory mechanisms that measure vasodilation 
and plasma extravasation. Also, its role has been examined in processes of maintenance 
and vascular renovation with substantial implications in visual function [23]. Thus, it has 
been suggested that changes in choroidal thickness would play a main role in the regula-
tion of this ocular refractive state, particularly in recuperation from myopia [22]. Addi-
tionally, the diabetes-like conditions induced by streptozotocin reduce the content of 
CGRP in the sensory nerves and exogenous CGRP-mediated vasodilation. CGRP is likely 
an important regulator of vascular tone, and compromising its function could contribute 
to nerve ischaemia and diabetic neuropathy [80]. It has been postulated that the dysfunc-
tion of SP(+) and/or CGRP(+) ICNs could be involved in the physiopathology of ocular 
diseases associated with peripheral innervation damage. The majority distribution of 
sympathetic and sensitive ICNs in the submacular region suggests the possibility that 
vascular pathologies of certain ocular diseases such diabetic macular oedema or age-
related macular degeneration are related to the possible dysfunction of these cells 
[20,21,52]. 
It appears that the peripheral innervation, both sensitive as well as sympathetic, would have 
a broad and significant role in regulating the choroidal vascular architecture. Moreover, 
given the special susceptibility to damage presented by peripheral innervation under a great 
variety of conditions (age, arterial hypertension, ocular hypertension, diabetes), sympathetic 
and sensitive choroidal nerve dysfunction could intervene in the aetiology of ocular diseases 
that appear in association with these conditions [21,52]. 
3. Hypercholesterolaemia as a risk factor for smooth-muscle and 
endothelial cell dysfunction 
Atherosclerosis results from a local imbalance between the production of reactive oxygen 
species (ROS) and antioxidant enzymes. The EC, macrophages, and VSMC are targets for 
ROS-dependent atherogenic signalling [81]. Our data suggest that changes in arterial ROS 
production may occur very early in hypercholesterolaemia. Atherosclerosis is initiated by 
lipids deposited in the subendothelial layer of the artery wall. These lipids and modified 
LDL, oxidized low-density lipoprotein (Ox-LDL), induce the expression of adhesion mole-
cules and chemotactic molecules including monocyte chemoattractant protein-1 (MCP-
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1/CCL2). After activating EC in this way, monocytes/ macrophages enter the intima and 
differentiate [82]. Lipid-laden macrophages, known as foam cells, promote the progression 
of the atherosclerotic plaque [83]. Specifically, pro-inflammatory cytokines and growth fac-
tors secreted by foam cells induce local inflammatory responses, ROS in the lesion, and 
accelerate the migration of VSMC from the media to the intima [84]. Intimal VSMC also take 
up modified lipoproteins, contributing to foam-cell formation, and synthesise extracellular 
matrix proteins (collagen, elastin, and proteoglycans) that lead to the development of a fi-
brous cap [85].  
In VSMC, ROS mediates various functions, including growth, migration, matrix regulation, 
inflammation, and contraction [86], which are critical factors in the progression and 
complication of atherosclerosis. VSMC regulate plaque stability by modulating 
inflammation and apoptosis and by producing or degrading matrix proteins [85,87]. Under 
atherogenic conditions, VSMC in the media of the artery undergo phenotypic changes from 
the normal contractile state to the active synthetic state, which produces collagen, elastin, 
and proteoglycans. Activated VSMC migrate to the intima and proliferate [88]. In addition, 
ROS produced via NADPH oxidase induce VSMC to produce and secrete matrix 
metalloproteinases involved in the degradation and reorganization of the extracellular 
matrix [89]. In VSMC, ROS also mediate inflammation (e.g., MCP-1 expression via TNF-α) 
[90] and apoptosis via p53 and Bax/Bad [91]. 
The junction integrity of EC in blood vessels regulates leukocyte transmigration. In this 
process, ICAM-1 and VCAM-1 clustering prompts actin remodelling and junction disrup-
tion via ROS production [82]. 
It has been reported that Ox-LDL affects endothelium-dependent responses [92]. Some stud-
ies demonstrate that Ox-LDL decreases the endothelial release of NO [93] and that endothe-
lium-dependent relaxations are improved by lipid-lowering therapy in patients with hyper-
cholesterolaemia [94]. Another study suggests a mechanism for the cholesterol-induced 
impairment of NO production through endothelial nitric oxide synthase (eNOS) regulation 
by inhibitory interaction with caveolin [95]. 
4. Animal models of hypercholesterolaemia 
Animal models provide a controlled environment in which to study disease mechanisms 
and to devise technologies for diagnosis and therapeutic intervention for human atheroscle-
rosis. Different species have been used for experimental purposes (cat, pig, dog, rabbit, rat, 
mouse, zebra fish). The larger animal models more closely resemble human situations of 
atherosclerosis and transplant atherosclerosis and can also be easily used in (molecular) 
imaging studies of cardiovascular disease, in which disease development and efficacy of 
(novel) therapies can be monitored objectively and non-invasively. Imaging might also ena-
ble early disease diagnosis or prognosis [96]. On the other hand, the benefits of genetically 
modified inbred mice remain useful, especially in quantitative trait locus (QTL)-analysis 
studies (a genetic approach to examine correlations between genotypes and phenotypes and 
to identify (new) genes underlying polygenic traits [96].  
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4.1. Mice 
Wild-type mice are quite resistant to atherosclerosis as a result of high levels of anti-
atherosclerotic HDL and low levels of pro-atherogenic LDL and very-low-density-
lipoproteins (VLDL). All of the current mouse models of atherosclerosis are therefore based 
on perturbations of lipoprotein metabolism through dietary or genetic manipulations [97].  
ApoE-knockout mice  
In apoliprotein-deficient mice (apoE-/-) the homozygous delection of the apoE gene results in 
a pronounced rise in the plasma levels of LDL and VLDL attributable to the failure of LDL-
receptor (LDLr-) and LDL-related proteins (LRP-) mediated clearance of these lipoproteins. 
As a consequence, apoE-/- mice develop spontaneous atherosclerosis. Of the genetically en-
gineered models, the apoE-deficient model is the only one that develops extensive athero-
sclerotic lesions on a low-fat cholesterol-free chow diet (<40g/kg). The development of ath-
erosclerosis lesion can be strongly accelerated by a high-fat, high-cholesterol (HFC) diet [98]. 
ApoE-knockout mice have played a pivotal role in understanding the inflammatory back-
ground of atherosclerosis, a disease previously thought to be mainly degenerative. The 
apoE-deficient mouse model of atherosclerosis can be used to: i) identify atherosclerosis-
susceptibility-modifying genes; ii) define the role of various cell types in atherogenesis; iii) 
characterize environmental factors affecting atherogenesis; and iv) to assess therapies [99]. 
Because of the rapid development of atherosclerosis and the resemblance of lesion to human 
counterparts, the apoE-/- model have been widely used. However, some drawbacks are asso-
ciated with the complete absence of apoE proteins: i) the model is dominated by high levels 
of plasma cholesterol; ii) most plasma levels are confined to VLDL and not to LDL particles, 
as in humans; and iii) apoE protein has additional antiatherogenic properties besides regu-
lating the clearance of lipoproteins such as antioxidant, antiproliferative (smooth-muscle 
cells, lymphocytes), anti-inflammatory, antiplatelet, and also has NO-generating properties 
or immunomodulatory effects [100-102]. The study of the above processes and the effects of 
drugs thereupon is restricted in this model.  
LDLreceptor-deficient mice (LDLr-/- mice) 
In humans, mutations in the gen for the LDLr cause familial hypercholesterolaemia. Mice 
lacking the gene for LDL receptor (LDLr-/- mice), develops atherosclerosis, especially when 
fed a lipid-rich diet [103]. The morphology of the lesions in LDLr-/- mice is comparable to 
that in apoE-/-, while the main plasma lipoprotein in LDLr-/- mice are LDL and high-density-
lipoprotein (HDL) [104].  
ApoE*3Leiden (E3L) transgenic mouse 
ApoE*3Leiden (E3L) transgenic mice are being generated by introducing a human ApoE*3-
Leiden construct into C57B1/6 mice. E3L mice develop atherosclerosis on being fed cholester-
ol. Because they are highly responsive to diets containing fat, sugar, and cholesterol, plasma 
lipid levels can easily be adjusted to a desired concentration by titrating the amount of cho-
lesterol and sugar in the diet. E3L mice have a hyperlipidaemic phenotype with a prominent 
 
Choroidal Vessel Wall: Hypercholesterolaemia-Induced Dysfunction and Potential Role of Statins 
 
271 
increase in VLDL- and LDL-sized lipoproteins fractions [105] and are more sensitive to li-
pid-lowering drugs than are apoE-/- and LDLr-/- mice [97]. 
4.2. Minipigs 
Because of their well-known physiological and anatomical similarities to humans, swine are 
considered to be increasingly attractive toxicological and pharmacological models. Pigs 
develop plasma cholesterol levels and atherosclerotic lesions similar to those of humans, but 
their maintenance is more difficult and expensive than that of smaller animals [96]. The 
minipig, smaller than the domestic swine, has served as a model of hypercholesterolaemia 
for more than two decades now. In 1986, Jacobsson reported that the Göttingen strain had 
more susceptibility to alimentary hypercholesterolaemia and experimental atherosclerosis 
than did domestic swine of the Swedish Landrace [106]. Clawn[107], Yucatan, Sinclair, and 
Handford are among other general minipigs used for experimental use [107-109]. Down-
sized Rapacz pigs are minipigs with familial hypercholesterolaemia caused by a mutation in 
the low-density lipoprotein receptor. It is a model of advanced atherosclerosis with human 
like vulnerable plaque morphology that has been used to test an imaging modality aimed at 
vulnerable plaque detection [110]. The Microminipig (MMP) is the smallest of the minipigs 
used for experimental atherosclerosis [111]. One of its advantages is that in 3 months an 
atherosclerosis very similar in location, pathophysiology and pathology to that in humans 
can be induced [112]. The easy handling and mild character of the MMP make it possible to 
draw blood and conduct CT scanning under non-anaesthesized conditions [113]. 
4.3. Zebra fish 
Cholesterol-fed zebra fish represent a novel animal model in which to study the early events 
involved in vascular lipid accumulation and lipoprotein oxidation [114,115]. Feeding zebra 
fish a high-cholesterol diet results in hypercholesterolaemia, vascular lipid accumulation, 
myeloid cell recruitment, and other pathological processes characteristic of early atherogen-
esis in mammals [113]. The advantages of the zebra-fish model include the optical transpar-
ency of the larvae, which enables imaging studies.  
4.4. Rabbits 
Investigation has continued on hypercholesterolaemic rabbits since 1913, when Anitschkow 
demonstrated that, in rabbits fed a hypercholesterolaemic diet underwent atherosclerotic 
changes at the level of the arterial intima similar to those in atherosclerotic humans. The 
atheromatose lesions in this animal are similar to those in humans also in sequence, as con-
firmed en aortic atherosclerosis [116], making this animal a universal model for studying the 
anti-atherogenic activity of many drugs [117-120]. For the characteristics detailed below, the 
New Zealand rabbit is an excellent model to reproduce human atheromatosis because: i) it is 
possible to induce hypercholesterolaemia in a few days after administration of a high-
cholesterol diet [121]; ii) it is sensitive to the induction of atheromatose lesions [116]; iii) 
Current Basic and Pathological Approaches to  
the Function of Muscle Cells and Tissues – From Molecules to Humans 
 
272 
hypercholesterolaemia results from excess LDL [122]; iv) excess cholesterol is eliminated 
from the tissues to be incorporated in high-density lipoproteins (HDL) [4]; vi) it is capable of 
forming cholesterol-HDL complexes associated with apoE which are transported by the 
blood to the liver [4]; vii) the lipoprotein profile is similar in size to that of humans in the 
highest range, with HDl being practically the same [123]; viii) it presents postprandial hy-
perlipaemia for the existence of chilomicron remnants [124]; ix) the hyperlipaemic diet in-
creases apoE [125]; and x) the sustained alteration of lipids after feeding with a cholesterol-
rich diet is reversible when the diet is replaced by a normal one [121]. 
Studies on hypercholesterolaemic rabbits have improved our knowledge of human athero-
sclerosis by delving into different aspects of the disease such as lipoproteins, mitogenes, 
growth factors, adhesion molecules, endothelial function, and different types of receptors. 
At the vascular level, the importance of endothelial integrity and cell adhesion has been 
investigated [126]. It has been demonstrated that the high levels of lysosomal iron start the 
oxidation of the LDL, spurring the formation of lesions [127]. In addition, the expression of 
VCAM-1 preceding the infiltration of the subendothelial space by macrophages has been 
studied [128], as have the proteins, including MCP-1. In hypercholesterolaemic rabbits, this 
protein is over-expressed when the serum-cholesterol levels rise in macrophages and 
smooth-muscle cells, contributing to the development of fatty streaks [2]. 
In hypercholesterolaemic rabbits, the expression de Fas-L in cells of the arterial wall help us 
to understand the progression of the atherosclerotic lesion, as this expression indicates an 
increase in cell injury, as well as a greater accumulation in the intima of smooth-muscle cells 
[8]. Also, a hyperlipaemic diet causes a selective alteration of the functioning of certain regu-
latory proteins that are involved in gene expression, as occurs with the nuclear B factor, 
which stimulates the proliferation of macrophages and smooth-muscle cells [129]. 
In this model, a study was also made of the pre-thrombosis state triggered by the platelet 
aggregation in an altered endothelium and the possibilities of its inhibition [130], as well as 
the interactions of the LDL with the extracellular matrix to form aggregates that accumulate 
in the intima of the artery wall [9]. 
The consequences of hypercholesterolaemia in ischaemic cardiopathy and cerebrovascular 
pathology are well known. The same does not occur with the functional repercussions of the 
hypercholesterolaemia at the ocular level, partly because the underlying structural changes 
are not well known. The hypercholesterolaemic rabbit constitutes a useful model to explore 
the repercussions of excess lipids at the ocular level. This is because rabbits are susceptible 
to both systemic as well as the ocular alterations. One of the broadest contributions made to 
the implications of experimental hypercholesterolaemia at the ocular level was that of 
Françoise and Neetens [131]. These authors, apart from analysing the changes in the liver, 
spleen, adrenaline glands, heart, aorta, and supra-aortic trunk, described the most signifi-
cant ocular findings, such as the accumulation of lipids in the choroid, retinal disorganiza-
tion, and lipid keratopathy. With respect to the retinal macroglia, the synthesis of the ApoE 
by the Müller cells, its subsequent secretion in vitro, and its being taken up by the axons and 
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transported by the optic nerve enabled the detection of ApoE in the latter geniculate body 
and in the superior colliculus [132]. 
Studies with electron microscopy on hypercholesterolaemic rabbits have revealed hypercel-
lularity and optically empty spaces in the corneal stroma. These optically empty spaces, 
with an elongated or needle shape, were previously occupied by crystals of cholesterol 
monohydrate or crystals of cholesterol esters [133]. In other studies, the analysis in the form 
adopted for the crystallizations of the different types of lipids revealed that the needles 
corresponded to esterified cholesterol, and the short, thin ones to triglycerides [4]. Both 
crystallizations appear to be associated with other components such as collagen. 
In addition, the formation of foam cells as a consequence of phagocytes from the macro-
phage-oxidized LDL has also been detected, with the retention of cholesterol in the vascular 
wall and the activation of ACAT (acetyl-cholesterol-acyl-transferase) [5], this point being 
key to the role of macrophages in the progression or regression of the lesions [4].  
Watanabe 
The Watanabe heritable hyperlipidaemic (WHHL) rabbit is an animal model for hypercho-
lesterolaemia due to genetic defects in LDL receptors [134] and a lipoprotein metabolism 
very similar to that of humans [135]. These features make WHHL rabbits a true model of 
human familial hypercholesterolaemia. The first paper on the WHHL rabbit was published 
in 1980 [136]. The original WHHL rabbits had a very low incidence of coronary atheroscle-
rosis and did not develop myocardial infarction. Several years of selective breeding led to 
the development of coronary atherosclerosis-prone WHHL rabbits, which showed metabolic 
syndrome-like features, and myocardial infarction-prone WHHLMI rabbits. WHHL rabbits 
have been used in studies of several compounds with hypocholesterolaemic and/or anti-
atherosclerotic effects with special relevance for statins [135]. Recently, WHHLMI rabbits 
have been used in studies of the imaging of atherosclerotic lesions by MRI [137], PET [138] 
and intravascular ultrasound [139]. 
5. Statins 
Hypercholesterolaemia is a known risk factor for cardiovascular disease, and statin therapy 
has led to a significant reduction in morbidity and mortality from adverse cardiac events, 
stroke, and peripheral arterial disease [140,141]. Statins block the enzyme necessary for the 
production of L-mevalonate, an intermediary product in cholesterol synthesis. One of the 
main actions of statins is to lower circulating cholesterol levels. Cholesterol is produced 
from acetoacetyl coenzyme A in a process consisting of 28 steps. Statins block the second 
step, the conversion of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) into L-
mevalonate. This is also the rate-limiting step of cholesterol synthesis, and is catalysed by 
HMGCoA reductase. Lower levels of cholesterol prompt the cell to up-regulate the LDL-
receptor. However, statin treatment also increases LDL-receptor degradation, so that the 
surface expression of the receptor remains unchanged. The receptor cycling is possibly in-
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creased, thus boosting the import of LDL-bound cholesterol into the cell and lowering the 
levels of circulating cholesterol as well [142].  
Statin structure can be divided into three basic parts: an analogue of HMG-CoA, a hydro-
phobic ring structure that aids in binding to HMG-CoA reductase, and side groups on the 
rings. These side groups determine statin solubility and, as a result, many of the pharmaco-
kinetic properties of statins. Atorvastatin, fluvastatin, lovastatin, pitavastatin, cerivastatin, 
and simvastatin are considered lipophilic, whereas pravastatin and rosuvastatin are consid-
ered hydrophilic as a result of polar side groups [140]. Although all statins can enter hepatic 
cells through either active or passive transport, hydrophilic statins, such as pravastatin and 
rosuvastatin are less likely to enter non-hepatic cells, while lipophilic statins, e.g. atorvas-
tatin and simvastatin are more likely to enter hepatic and non-hepatic cells through passive 
diffusion. This difference in tissue permeability and metabolism may account for some of 
the differential pleiotropic effects among the statins [143,144]. Not all statins cross the blood-
brain barrier (BBB). Short-term statin treatment does not alter cholesterol levels in the brain. 
The more lipophobic statins such as pravastatin cannot cross the BBB. However, the lipo-
philic statins lovastatin and simvastatin are capable of such a crossing, although they reach 
only a relatively low concentration [145]. 
Recent compelling evidence suggests that the beneficial effects of statins may be due not 
only to their cholesterol-lowering effects, but also to their cholesterol-independent or plei-
otropic effects [140,142,143]. These cholesterol-independent effects include improving endo-
thelial function, attenuating vascular and myocardial remodelling, inhibiting vascular in-
flammation and oxidation, and stabilizing atherosclerotic plaques [144]. The mechanism 
underlying some of these pleitropic effects is to inhibit the conversion of HMG-CoA to L-
mevalonic acid. This inhibition prevents the synthesis of important isoprenoid intermediates 
of the cholesterol biosynthetic pathway, such as farnesylpyrophosphate (FPP) and geranyl-
geranylpyrophosphate (GGPP) [146]. Both intermediates have indirect but important roles 
in vascular structure and function. These two isoprenoids are both used to provide proteins 
with lipophilic attachments to the cell membrane. Two protein families that require these 
lipophilic attachments for appropriate localization within the membrane and proper func-
tional activity are the Ras and Rho families of small G proteins. Without modification of Ras 
by farnesylation and Rho by geranylgeranylation, neither protein can function properly or 
localize to its appropriate place within the cell membrane. Furthermore, both Ras and Rho 
are vital components of second messenger systems known to affect vascular inflammation, 
hypertrophy, and hyperplasia. These second messenger systems are also intimately in-
volved in promoting vascular remodelling in disease states such as atherosclerosis and dia-
betes [140]. 
Hypercholesterolaemia interferes with endothelial function, resulting in impaired synthesis, 
release, and activity of endothelial NO [147]. The mechanism by which LDL-cholesterol 
(LDL-C) causes endothelial dysfunction and decreases NO bioactivity involves downregula-
tion of endothelial NOS expression, diminished receptor-mediated NO release, and less NO 
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bioavailability owing to greater ROS production [146]. LDL-C apheresis can improve endo-
thelium-dependent vasodilatation, which indicates that statins could restore endothelial 
function, in part by lowering serum LDL-C levels. Cholesterol lowering alters atherosclerot-
ic-plaque biology, thereby decreasing vascular inflammation and leukocyte activation. Thus, 
statins can improve endothelial function by lowering serum cholesterol levels. However, in 
some studies, statins improve endothelial function before significant change in serum-
cholesterol levels. Statins accelerate endothelial NO production by stimulating and upregu-
lating endothelial NO synthase (eNOS), especially in the presence of hypoxia and oxidized 
LDL [147]. 
Statins affect eNOS expression and activity mainly through three mechanisms. First, 
statins increase eNOS expression by prolonging eNOS mRNA half-life rather than by 
inducing eNOS gene transcription. Second, statins reduce caveolin-1 abundance, an inte-
gral membrane protein that binds to eNOS in caveolae, thereby directly inhibiting NO 
production. Third, statins can activate the phosphatidylinositol 3-kinase (PI3K)/protein 
kinase Akt pathway. Akt is a serine/threonine kinase that regulates various cell functions, 
such as survival, growth and proliferation. Because Akt, in turn, phosphorylates and 
activates eNOS, statins can also increase eNOS activity through the PI3K/Akt pathway 
[146]. 
Statins may also improve endothelial function through their antioxidant effects. For ex-
ample, statins enhance endothelium-dependent relaxation by inhibiting production of 
reactive oxygen species, such as superoxide and hydroxyl radicals, from aortas of choles-
terol-fed rabbits [148]. Although lipid lowering by itself can reduce vascular oxidative 
stress, some of these antioxidant effects of statins appear to be cholesterol independent. 
Indeed, they can attenuate angiotensin II-induced production of the highly oxidative (free 
radical) species in VSMC and downregulate angiotensin-1 receptor expression. Because 
NO is scavenged by reactive oxygen species, these findings indicate that the antioxidant 
properties of statins may also contribute to their ability to improve endothelial function 
[147]. 
Vascular smooth-muscle cell migration and proliferation are two other major components of 
both atherogenesis and neointimal hyperplasia, and both of these components are affected 
by statin administration [140]. The small G proteins Ras and Rho, which play a large role in 
VSMC migration and proliferation, are plausible targets for the direct antiproliferative vas-
cular effects of statins [143]. Statin administration is able to attenuate these effects of both 
small G-protein families [140]. Simvastatin inhibits both VSMC proliferation and migration 
in a series of experiments with human saphenous vein grafts [149]. 
In summary, statins could be beneficial not only for their lipid-lowering properties but for 
their other effects referred to as pleiotropic -that is, their capacity to restore endothelial func-
tion, to stabilize atherosclerotic plaque, or to alleviate oxidative stress and vascular inflam-
mation [150-153]. Such effects have been demonstrated in rabbits fed cholesterol at a dose 
insufficient to reduce plasma-cholesterol levels [55,148].  
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6. Choroidal changes induced by hypercholesterolaemia 
Few experimental studies examine the effects of hypercholesterolaemia on the posterior 
segment of the eye [154-159]. Hypercholesterolaemic rabbits constitute a useful model to 
delve into the repercussions of excess lipids at the ocular level. Rabbits fed a 0.5% choles-
terol-enriched diet for 8 months showed a statistical increase in total serum cholesterol 
and in the sclera-choroid complex thickness in comparison to control [6,157,158,160,161] 
(Figure 9).  
The increased choroidal thickness is due mainly to clusters of lipid-charged macrophages 
(foam cells) which are surrounded by collagen fibres in the suprachoroid. In some instances, 
the foam cells and fibroblasts have ultrastructural features of necrosis, with a rupture of the 
cytomembranes. In addition, the clusters of foam cells are encircled by cholesterol clefts 
[6,160] (Figure 10A). As a result of the lipid accumulation in the suprachoroid and in the 
large- and medium-size-vessel layers, the lumens of the choroidal vessels are mechanically 
compressed and the choroidal blood flow constricted (Figures 11B,12B). This situation also 
affects the choriocapillaris, which is compressed against Bruch’s membrane, the capillary 
lumens being reduced to the point of collapse in some instances [6,160] (Figure 11B). How-
ever, the lumen reduction in the choroidal vessels of hypercholesterolaemic rabbit is due not 
only to the compression caused by the lipid build-up in the suprachoroid and vessel layers 
but to the changes of the VSMC and EC. The VSMC in the large- and medium-sized-vessel 
layer are hypertrophic with a compact appearance (Figure 12B), while EC in these layers 
and in the choriocapillaris show rarefactions in the cytoplasm that contribute to vascular 
lumen reduction (Figure 12B). The cytoplasm organelles show similar changes in VSMC and 
EC. The endoplasmic reticulum and Golgi cisterns are dilated, the ribosomes are disassem-
bled, the mitochondria appear swollen, the caveolar system is smaller than in normal cho-
roid (Figure 13A,E,F), and the cytoplasm contains droplets of lipids and dense bodies. In 
VSMC the myofilaments are disorganized, with areas of focal necrosis affecting the dense 
plaques (Figure 13F). In the areas where the tissue was highly disorganized, other necrotic 
features (swelling, vacuolization, cytomembrane necrosis, and the disappearance of specific 
ultrastructural characteristics) are visible in both cell types [6,160] (Figure 13E,F). 
The endothelial alterations described above could be explained, at least partly, by the 
Posieulle’s law, which states that tangential tension is directly proportional to the blood-
flow viscosity and inversely proportional to the third power of the inside radius. According-
ly, reduction of the choroidal vascular lumens in hypercholesterolaemic rabbits could in-
crease the local tangential force exerted by the choroidal blood flow on the vessel walls. 
With time, these changes in blood flow could lead to a reorganization of the endothelial 
phenotype, resulting in endothelial dysfunction [162]. Endothelial changes and basal-
membrane thickening of ocular vessels in hypercholesterolaemic rabbits may precede the 
atherosclerotic process. In the hypercholesterolaemic rabbits, the basal membrane of EC and 
VSMC contained electrodense and electrolucent particles and were thicker than in the nor-
mal choroid.  
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In the atherosclerotic process, the adhesion molecules VCAM-1 and ICAM-1 favour mono-
cyte binding and migration to the subendothelial space, where they transform into macro-
phages [3,4]. In iris arterioles of hypercholesterolaemic rabbits, the internalization of lipids 
by macrophages results in the formation of foam cells [163]. Foam cells are also found in the 
suprachoroid and large- and medium-sized-vessel layers of hypercholesterolaemic rabbits 
[6,160]. Before and after dying, foam cells may release products such as cholesterol (oxidized 
and esterified) that increase endothelial damage, thus encouraging the atherosclerotic lesion. 
The foam cells underneath the basal membrane of the large-sized-vessel layer [6,160], where 
the vessels have a diameter of up to 90 μm [15], could represent the microatheromas de-
scribed in brain circulation [164]. In the medium-sized-vessel layer, arterioles with diame-
ters ranging from 20 to 40 micrometers [15], combined with the increased collagen detected 
in the adventitia and the lipid deposits (electron-dense vesicles) inside muscle cells [6,160], 
could produce arteriolar hyalinosis [164].  
  
Figure 9. Thickening of the sclera-choroid complex (double arrow) in the study groups. Semithin sec-
tions (toluidine blue).(C: vascular layers of the choroid; SC-S: suprachoroidea-sclera). [Control: standard 
diet; Hypercholesterolemic: 0.5% cholesterol-enriched diet for 8 months; Reverted: 0.5% cholesterol-
enriched diet for 8 months plus standard diet for another 6 months; Statins: Hypercholesterolemic diet + 
fluvastatin sodium or pravastatin sodium for 8 months]. Scale bar, 100 μm. (Modified from Salazar et al 
[6] and Rojas et al. [55]). 
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Figure 10. Electron micrographs of the suprachoroidea. A: Hypercholesterolemic rabbit. The image 
shows a large amount of lipid containing foam cells as well as collagen fibers and cholesterol clefts 
between them. B: Reverted animals. The collagen fibres predominate over the foam cells and cholesterol 
clefts. C: Statin-treated animals. An increase in collagen is observed. The lipids are located mainly inside 
the fibroblast. [Foam cells (asterisk); lipids (arrowhead); cholesterol clefts (arrow); collagen (C); fibro-
blast (F)]. Scale bars: 5 μm. (Image B from Salazar et al. [6]). 
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Figure 11. Electron micrographs of large- and medium sized-vessel layers and choriocapillaris. A: 
Spongy structure of the choroid of a control animal. B: In the hypercholesterolemic group the vascular 
lumens were reduced to the point of collapse in some instances. C: In the reverted animals, choroidal 
changes make difficult to differentiate the choroidal layers. D: The vascular lumens of statin-treated 
animals were opened in part due to the reduction of suprachoroidal lipids. [Bruch’s membrane (B); 
collagen (C); choriocapillaris (CC); endothelial cell (E); fibroblast (F); vascular lumen (L); lipids (arrow); 
vascular smooth-muscle cells (M); retinal-pigment epithelium (RPE); large- and medium-sized vessel 
layers (S); Red blood cells (*) outside the vascular lumens; macrophage (mac)]. [Bars: A,B, 10 μm; C,D 5 
μm]. (Modified from Salazar et al [6] and Rojas et al. [55]). 
Studies examining the aortic preparations of hypercholesterolaemic rabbits indicate that, at 
sites where the luminal side was covered by fatty streaks, the number of caveolae in the EC 
was significantly lower [165]. Caveolae are distinctive cholesterol-enriched invaginations of 
the plasma membrane of the most mammalian cells. Caveolin is an essential component of 
caveolas, and their expression in cells results in the assembly of caveolae at the cell surface. 
There is an emerging role of caveolae, in organizing and modulating the basic functions of 
smooth muscles [166] and vascular functions dependent on NO and Ca2+ signalling 
[166,167]. Caveolin proteins tightly bind cholesterol and contribute to the regulation of cho-
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lesterol fluxes and distribution within cells [168]. It has been reported that in the early stages of 
hypercholesterolaemia, caveolin-1 synthesis increases to remove the excess cholesterol from 
the cells. However, after long periods of cholesterol feeding, caveolin-1 synthesis was re-
pressed [169]. In [95] reported the cholesterol-induced impairment of NO production through 
the modulation of caveolin abundance in EC as a mechanism that may be involved in the 
pathogenesis of endothelial dysfunction. In hypertensive rats, it has been postulated that a 
decreased number of caveolae could be the reason for the impaired relaxation by NO donors. 
Additionally, in rabbits, after a long period (12 weeks) of ingesting a high-cholesterol diet, both 
the level of caveolin-1 and the activity of NOS declined [169]. EC and VSMC in hypercholes-
terolaemic rabbits (8 months of hypercholesterolaemic diet) exhibit less caveolae than did 
control animals (Figure 13A,F), a situation that could contribute to the deposit of circulating 
molecules, such as LDL, which are detected as electrolucent or electrodense particles of vary-
ing size. A decrease in caveola abundance has been postulated to represent a novel mechanism 
of endothelial dysfunction in atheromatous rabbit aorta [165,170]. This idea is supported by 
the fact that a pharmacological disruption of endothelial caveolae also results in the attenua-
tion of acetylcholine-induced relaxation [165,170]. 
7. Choroidal changes after diet-induced normalization of plasma lipid 
levels  
It has been established that the atherosclerotic lesions can undergo regression in 
experimental animals such as rabbits, dogs, and non-human primates [171]; and the lack of 
progression or even regression can occur in humans, especially with the introduction of new 
therapeutical options [172].  
Knowledge of the changes arising after the normalization of the cholesterol values in a 
vascular tissue such as the choroid can be useful to evaluate the effects of the different drugs 
for hypocholesterolaemia. Animal models offer a useful tool for studying lesion regression 
after cholesterol-serum values normalize. When excessive cholesterol is withdrawn from the 
diet of rabbits, these animals recover some of the biochemical and histological parameters 
that are altered in cholesterol-fed animals [6,173]. It has been reported that the serum 
concentration of total cholesterol, triglycerides, phospholipids, VLDL, HDL, LDL, and 
intermediate-density lipoprotein (IDL) increased in rabbits fed a 0.5% cholesterol-enriched 
diet for 8 months. When the same animals were then fed a standard diet for another 6 
months, (reverted animals), lipid values returned to normal. Notably, the normalization of 
serum values was not followed by a complete recovery of the histology of the retina [158], 
choroid, or thoracic aorta [6]. In reverted rabbits, the sclera-choroid complex thinned 
compared with that of hypercholesterolaemic animals, due to having far fewer clusters of 
foam cells encircled by cholesterol clefts in the suprachoroid (Figure 9). However, these 
tissues had not yet reached the normal thickness values of control due to the increase in 
collagen fibres [6] (Figures 10B,11C). This marked reduction in the suprachoroidal build-up 
of lipids implies less compression of the vessels. Such findings have also been reported in 
the iris and cornea of hypercholesterolaemic reverted rabbits [174]. However, although in 
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most cases fewer lipids were found in the suprachoroidal spaces in reverted rabbits, there 
were still numerous ultrastructural changes in comparison with hypercholesterolaemic and 
normal rabbits. These changes could contribute to chronic ischaemia, for several reasons: i) 
The large- and medium-sized-vessel layers still exhibited alterations in VSMC and EC that 
could impair vascular function. Specifically, the cytoplasm organelles (endoplasmic 
reticulum, Golgi cisterns, ribosomes, mitochondria, and caveolar system) of VSMC and EC 
in the reverted rabbits showed changes similar to hypercholesterolaemic animals. Also, in 
zones where the tissue was highly disorganized, necrotic features (swelling, vacuolization, 
cytomembrane necrosis, and disappearance of specific ultrastructural characteristics) were 
noted [6] (Figures 11C,12C). ii) The EC of the choriocapillaris extended cytoplasmic 
projections that reduced the vascular lumen (Figure 12C). iii) Finally, the intervascular 
spaces of the choroid contained fewer lipids than in hypercholesterolaemic animals but 
more collagen fibres than in control (Figures 11A,C,12A,C).  
 
Figure 12. Electron micrographs of large- and medium sized-vessel layers of the choroid. A: Control 
animals. B: In the hypercholesterolemic animals the vascular lumens are reduced. The muscle cells are 
hypertrophic and contain drops of lipids (*) in the cytoplasm. Additionally, the endothelial cells are 
hypertrophic and/or necrotic. The basal membrane is thick. C: Reverted animals maintained the reduc-
tion of the vascular lumen and the thickening of the adventitia. D: In animals treated with statins vascu-
lar lumens, vascular smooth-muscle cells, endothelial cells and basal membrane were more similar to 
the control group. [collagen (C) ; endothelial cell (E); vascular lumen (L); vascular smooth-muscle cells 
(M); basal membrane (bm); adventitia (Ad)]. [Bars: A,B, D 5 μm; C 2 μm]. (Modified from Salazar et al 
[6] and Rojas et al. [55]). 
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This increase in collagen fibres was also found in the intima, among VSMC and in the ad-
ventitia (Figure 12C) of the large- and medium-sized-vessel layer and in the basal mem-
brane of the EC of the choriocapillaris [6]. It is well known that the reabsorption of both 
esterified and free cholesterol is followed by intense sclerogenic activity [175], due to the 
capacity of cholesterols and their esters to induce inflammation. Some inflammatory cyto-
kines (TNFα and IL-1) control the remodelling activity of macrophages and smooth-muscle 
cells, which have the capacity to produce several matrix metalloproteinases (MMPs) 
[176,177]. It has been observed that such MMPs are synthesised mainly where the concentra-
tion of foam cells is greatest and that there is a relationship between lipid uptake and MMP 
activity [177]. The observations cited above underline the strong connection between in-
flammation, tissue remodelling, and lipid metabolism.  
In summary, in hypercholesterolaemic rabbits the replacement of a hyperlipidaemic diet by 
a standard one normalized serum-lipid levels and eliminated most lipid build-up in the 
posterior segment of the eye. However, this lipid reduction was not followed by a reversal 
of the changes in choroidal vessels, where persisting ultrastructural changes in VSMC, EC, 
and extracellular matrix were compatible with a chronic ischaemia.  
8. Choroidal changes after low-dose statin treatment 
As mentioned above, it is well known that statins can exert cholesterol-independent or plei-
tropic effects which involve the restoration of endothelial function, stabilization of the ath-
eromatous plaque, reduced oxidative stress, lower vascular inflammation, immunomodula-
tion, and inhibition of VSMC proliferation [146,150,153,178]. Fluvastatin sodium (a lipophilic 
synthetic statin metabolised by the liver) and pravastatin sodium (a hydrophilic statin of 
fungal origin) can induce the regression of atherosclerosis besides reducing plasma choles-
terol [148,179]. 
It has been reported that 2 mg/kg/day of fluvastatin sodium and pravastatin sodium exerts 
an anti-atherosclerotic effect that appeared not to be mediated by the lipid-lowering proper-
ties of the drugs [150,180,181]. A 12.5-50 mg/Kg/day dosage of fluvastatin effectively reduces 
plasma lipids in Watanabe heritable hyperlipidaemic rabbits [182]. On the contrary, 2 
mg/Kg/day of fluvastatin did not lower plasma-cholesterol levels but did contribute to the 
impaired endothelium-dependent relaxation response in aortic rings [148] and femoral ar-
teries of cholesterol-fed rabbits [150]. 
According with reference [148], hypercholesterolaemic rabbits treated with fluvastatin sodi-
um and pravastatin sodium at a non-lipid-lowering dosage (2 mg/kg/day) showed a very 
small descent in plasma cholesterol and triglycerides levels [55]. In comparison with hyper-
cholesterolaemic rabbits, low-dose statin-treated animals had far fewer lipids in the supra-
choroid (the foam cells were decreased or absent), triggering a significant thinning of the 
sclera-suprachoroid complex (p< 0.000) (Figure 9). This reduction in the build-up of lipids 
relieved the mechanical compression of the vascular layers of the choroid and lead to nor-
malization of the spongy texture of the choroid [55] (Figure 11D). However, statin-treated 
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animals bore some alterations not present in control animals, such as clumps of electrodense 
particles, some foam cells, and fibroblast-containing lipids in the suprachoroid (Figure 
10C) or a significant thickening of the vascular layers because the vascular lumens were 
open [55] (Figures 11D,12D). The lack of lumen closure in low-dose statin-treated rabbits 
(unlike that observed in hypercholesterolaemic rabbits) suggests that the choroidal blood 
flow was not compromised and that endothelial dysfunction would not result in part 
because of the lesser stress on EC by means of a weakening of the local tangential forces 
exerted on the vessel walls when the inner vascular radius decreased [55]. In addition, in 
low-dose statin-treated animals, signs of necrosis were rarely found (Figure 13B,C), the 
EC looked similar to those of control (Figure 13A-D), the cytoplasmic organelles were 
normal (Figure 13B,D), and the caveolar system was more numerous than in hypercholes-
terolaemic rabbits [55] (Figure 13B,D-F). This increment of caveolae detected in the low-
dose statin-treated animals could account for the better preservation of endothelial func-
tion and could contribute to the normalization of vascular lumens observed in these ani-
mals. It has been proposed that caveolae could be specialized plasmalemmal regions in-
volved in the integration of extracellular contractile signals and intracellular effectors in 
VSMC [183]. Three findings in low-dose statin-treated rabbits led to speculation that 
treatment improved VSMC function: first, the increased amount of caveolae observed and 
their location close to the underlying network of peripheral sarcoplasmic reticulum; se-
cond, VSMC were not hypertrophic and exhibited the elongated shape observed during 
relaxation [55]. This contrasted with the compact, round, and short shape exhibited by 
VSMC in hypercholesterolaemic rabbits, which was compatible with a contractile state; 
and third, the absence of areas of focal necrosis related to the dense plaques in low-dose 
statin animals.  
A noteworthy finding in the cytoplasm of the EC and VSMC in the low-dose statin-treated 
group was that the cytoplasmic organelles were normal. Particularly the mitochondria 
maintained a normal electrodensity of the matrix, and the cristae and membranes were 
well preserved (Figure 13D). This is of outstanding importance, taking into account that 
these organelles represent a fundamental structure in the aerobic metabolism [184] and 
that they are extremely sensitive to hypoxia. The importance of mitochondria is well 
known in oxidative phosphorylation to generate ATP. Mitochondrial phosphorylation is 
impaired in ischaemic situations and, as a consequence of oxidative stress, DNA, proteins, 
and lipids, is damaged by a surge in free radicals [185]. From the mitochondrial integrity 
found in low-dose statin-treated rabbits, good functioning of EC and VSMC could be 
deduced. The normal ultrastructure of EC and VSMC suggests that the endothelium-
depending relaxation is maintained, thus reducing the ischaemia. According to ultrastruc-
tural examinations in the choroidal vascular tissue, the effects of low-dose statins are 
probably mediated by an overregulation of the endothelial NO and a downregulation of 
endothelin-1, as reported in studies on the direct consequences of the endothelial dysfunc-
tion in extraocular tissues [180]. This hypothesis should be tested by functional studies on 
ocular vascular reactivity. Another remarkable observation in low-dose statin-treated 
rabbits was that the basal membranes resembled control. However, it should be men-
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tioned that an increase in collagen fibres in the vascular adventitia and in the intervascu-
lar spaces, and even fibroblast containing clumps of lipids could still be detected (Figures 
11D,12D). These features can be explained firstly by the low lipid-decreasing capability of 
statins at the dosage of 2 mg/kg/day used in the study and, secondly, to macrophage ac-
tivity and their ability to produce MMPs [176,177] in the areas of higher concentrations of 
foam cells, where esterified and free-cholesterol reabsorption is followed by sclerogenic 
activity [175].  
 
Figure 13. Electron micrographs of endothelial and vascular smooth-vessel cells (VSMC). A: Control 
animal. The insert shows the normal ultrastructure of the myofilaments and caveolar system. B, C, D: 
Statin-treated rabbits. B,C: Intact caveolar system and cytoplasmic organelles. D: Elongated VSMC 
with well-preserved mitochondria, caveolae, and peripheral sarcoplasmic reticulum. The nucleus 
and perinuclear cisterns are normal. E, F: Hypercholesterolemic rabbits. E: Rounded and hyper-
trophic VSMC. Swollen mitochondria with loss of the cristae. The caveolae are decreased and the 
intercellular space increased (asterisk) in some instances. F: Area of focal necrosis below the plasma 
membrane (large black arrow). Dilated endoplasmic reticulum (arrowhead). The myofilaments are 
disorganized. Drops of lipids (white arrow) in VSMC (insert). [basal membrane (bm); endothelial cell 
(E); Golgi (g); vascular lumen (L); vascular smooth muscle cells (M); mitochondria (m); Caveolae 
(small black arrow)]. [Scale bars: A,D,E,F, 1 μm; A insert, 0.25 μm; B,F insert 5 μm; C, 0.5 μm.]. (From 
Rojas et al. [55]) 
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In hypercholesterolaemic New Zealand rabbits, treatment with fluvastatin sodium and 
pravastatin sodium at a dose (2mg/Kg/day) insufficient to normalize plasma-lipid levels 
prevents the progression of atherosclerosis in the different vascular layers of the choroid; the 
most striking effects being seen in EC and VSMC. 
9. Conclusions and perspectives 
Clinical studies have suggested that hyperlipidaemia alone can prompt structural changes 
in the choroidal vascular and retinal system that, over time, could provoke retinal 
dysfunction. This situation of chronic ischaemia is also present in causes of blindness as 
prevalent as aged-related macular degeneration, glaucoma or diabetic retinopathy [11-13]. 
This situation is extremely important, as today we know from epidemiological studies the 
relation between vascular retinal lesions and the incidence of lesions in non-ocular tissues 
that appear to be linked to common factors having microvascular effects. Statins are 
cholesterol-lowering medications. The treatment of hypercholesterolaemic rabbits with a 
non-lipid-lowering dose of statins dramatically reduces the ultrastructural choroidal 
damage induced by a sustained cholesterol-enriched diet [55]. This implies better choroidal 
flow and consequently oxygenation of the external retina, reducing chronic ischaemia [157]. 
It is well known that statins can exert cholesterol-independent or pleitropic effects [11] 
which involve the restoration of endothelial function, stabilization of atheromatous plaque, 
reduced oxidative stress, or lower eye inflammation [150,153,178]. These effects are 
potentially decisive in maintaining normal endothelial and smooth-muscle function and in 
improving endothelium-dependent relaxation. It bears noting that the most striking effects 
of low-dose statins in hypercholesterolaemic rabbits are the normalization of the 
ultrastructure of EC and VSMC, specifically cytoplasm organelles and caveolar system. Such 
effects suggest a possible role of statins in those ocular diseases having endothelial 
dysfunction in their physiopathology such as AMD, glaucoma or diabetic retinopathy, 
among others. 
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